13-20519465-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_015974.3(CRYL1):c.41+6289G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.845 in 152,070 control chromosomes in the GnomAD database, including 57,207 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.84 ( 57207 hom., cov: 31)
Consequence
CRYL1
NM_015974.3 intron
NM_015974.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.135
Publications
5 publications found
Genes affected
CRYL1 (HGNC:18246): (crystallin lambda 1) The uronate cycle functions as an alternative glucose metabolic pathway, accounting for about 5% of daily glucose catabolism. The product of this gene catalyzes the dehydrogenation of L-gulonate into dehydro-L-gulonate in the uronate cycle. The enzyme requires NAD(H) as a coenzyme, and is inhibited by inorganic phosphate. A similar gene in the rabbit is thought to serve a structural role in the lens of the eye. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.977 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CRYL1 | NM_015974.3 | c.41+6289G>A | intron_variant | Intron 1 of 7 | ENST00000298248.12 | NP_057058.2 | ||
| CRYL1 | NM_001363647.2 | c.41+6289G>A | intron_variant | Intron 1 of 6 | NP_001350576.1 | |||
| CRYL1 | XM_005266416.6 | c.41+6289G>A | intron_variant | Intron 1 of 5 | XP_005266473.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.845 AC: 128412AN: 151952Hom.: 57184 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
128412
AN:
151952
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.845 AC: 128472AN: 152070Hom.: 57207 Cov.: 31 AF XY: 0.851 AC XY: 63231AN XY: 74338 show subpopulations
GnomAD4 genome
AF:
AC:
128472
AN:
152070
Hom.:
Cov.:
31
AF XY:
AC XY:
63231
AN XY:
74338
show subpopulations
African (AFR)
AF:
AC:
21899
AN:
41410
American (AMR)
AF:
AC:
13989
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
3158
AN:
3472
East Asian (EAS)
AF:
AC:
5166
AN:
5166
South Asian (SAS)
AF:
AC:
4667
AN:
4828
European-Finnish (FIN)
AF:
AC:
10542
AN:
10584
Middle Eastern (MID)
AF:
AC:
265
AN:
294
European-Non Finnish (NFE)
AF:
AC:
66123
AN:
68016
Other (OTH)
AF:
AC:
1829
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
726
1451
2177
2902
3628
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
860
1720
2580
3440
4300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3356
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.